Owl butterflies amazingly ward off foes by disguising themselves as owls, thanks to wings that mirror the eyes of the woodland air predators. Flagship Pioneering is looking to build a new class of ...

In its ongoing mission to find the next Wegovy, Novo Nordisk has penned another partnership to seek out next-gen obesity treatments. This time, it's a $600 million biobucks pact with Flagship-founded ...

An owl butterfly is not speedy in flight, but the sight of its wings makes creatures think twice about making it a quick meal. The wing pattern resembles the eye of an owl. This ability to mimic a top ...

The company's MIMiC™ platform drives unprecedented insights into molecular interactions to design new biomolecules precisely tuned for therapeutic benefit With $50 million in committed capital from ...

CAMBRIDGE, Mass., Sept. 9, 2025 /PRNewswire/ -- Metaphore Biotechnologies, a Flagship Pioneering-founded generative AI drug design company focused on creating a new class of functional antibodies, ...

(Reuters) -Novo Nordisk signed a research tie-up with U.S. biotech firm Metaphore on Thursday to develop next-generation obesity drugs. WHY IT'S IMPORTANT Danish drugmaker Novo is trying to expand ...

After two years of development at Flagship Pioneering, start-up Metaphore Biotechnologies emerged on May 16 with $50 million of series A funding. It plans to tackle autoimmune and metabolic diseases ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A new spinout of Cambridge ...

St. Louis, Mo., August 1, 2001 – The National Cancer Institute of the National Institutes of Health (NIH) has awarded a six-month $104,000 Small Business and Innovation Research (SBIR) grant to ...

Novo in January announced research collaborations with two biotech firms Omega Therapeutics and Cellarity, both of which were founded by U.S. investment firm Flagship Pioneering. Danish drugmaker Novo ...